Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-518544-21-00Phase 4Authorised
Phase 4, randomised trial in colorectal cancer (CRC) comparing Plenvu with Picoprep (2 arms). Primary endpoint: Efficacy non-inferiority of Plenvu vs Picoprep. Planned start Nov 2024; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-518544-21-00.